Hans Biomed Corp. | Mutual Funds
Mutual Funds that own Hans Biomed Corp.
Templeton Emerging Markets Small Cap Fund
435,466
4.42%
0
1.29%
03/31/2018
FTIF SICAV - Templeton Emerging Markets Smaller Companies
344,535
3.5%
0
0.93%
06/30/2018
DFA Emerging Markets Small Cap Series
62,852
0.64%
0
0.02%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
47,046
0.48%
5,180
0.01%
04/30/2018
DFA Emerging Markets Social Core Equity Portfolio
1,476
0.02%
0
0%
04/30/2018
Old Westbury Small & Mid Cap Fund
1,441
0.02%
0
0%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
1,407
0.01%
0
0%
12/31/2017
John Hancock II - Emerging Markets Fund
1,340
0.01%
0
0%
04/30/2018
DFA TA World (ex-US) Core Equity Portfolio
747
0.01%
0
0%
04/30/2018
DFA World (ex-US) Core Equity Portfolio
730
0.01%
0
0%
04/30/2018
| Address |
7 Jeongui-ro 8-gil
Seoul SL 05836
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.hansbiomed.com |
| Updated |
09/14/2018 |
| HansBiomed Co., Ltd. engages in the manufacture and sale of graft material and silicon products. Its products include skin and bone graft material, silicon material, and other medical appliances. The company was founded on September 15,1999 and is headquartered in Seoul, South Korea. |
